| 000 | 01523 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513200551.0 | ||
| 264 | 0 | _c20000207 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1046/j.1365-2249.2000.01082.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFont, J | |
| 245 | 0 | 0 |
_aIncreased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE). _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cJan 2000 |
||
| 300 |
_a169-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Antinuclear _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aL-Selectin _xblood |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aPizcueta, P | |
| 700 | 1 | _aRamos-Casals, M | |
| 700 | 1 | _aCervera, R | |
| 700 | 1 | _aGarcía-Carrasco, M | |
| 700 | 1 | _aNavarro, M | |
| 700 | 1 | _aIngelmo, M | |
| 700 | 1 | _aEngel, P | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 119 _gno. 1 _gp. 169-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2249.2000.01082.x _zAvailable from publisher's website |
| 999 |
_c10562966 _d10562966 |
||